{"cell_type":{"d31e45ac":"code","d8071865":"code","99109e77":"code","89c36f5d":"code","ef1e383b":"code","a47b16ac":"code","3c4c090f":"code","14dd39bb":"code","5d33e86f":"code","0be83988":"code","23929b43":"code","1a94614e":"code","ec7d9df7":"code","22b314ee":"code","fec87f17":"code","fa9f92d0":"code","2a1f7b92":"code","231c2412":"code","acfe2249":"code","710b5c95":"code","0695a956":"code","fcfc7ef5":"code","7575199b":"code","e1047a9b":"code","66edcd1a":"code","30778508":"code","0499018f":"code","2daa904a":"code","813f7ef8":"code","f2c8ad17":"code","c573c3c5":"code","a9a1e3c7":"code","493f3c96":"code","8f3cc45d":"code","4511f025":"code","21f37196":"code","c73dc248":"code","0fef5334":"code","c22cf918":"code","669c10b6":"code","c66950df":"code","3871aadc":"code","30f222e9":"code","d2601f64":"code","6fd97a60":"code","0ba51ad2":"code","bb2b77a8":"code","b11751af":"code","0897e664":"code","9ce15924":"code","86145c91":"code","61cb9062":"code","8f1c0028":"code","27b61285":"code","ba4e22d2":"code","1ce2003c":"code","baf91510":"code","df63ed72":"code","e7c2dbc1":"code","dbe31de4":"markdown","725d34b5":"markdown","c7885bda":"markdown","ecd8f5e8":"markdown","074520e7":"markdown","1175c183":"markdown","a0fd1493":"markdown","0033eb9d":"markdown","a19dbac1":"markdown","9bc63a69":"markdown","fafefd57":"markdown","2ee085a8":"markdown","76f2bac4":"markdown","29a14a99":"markdown","dd7f8105":"markdown","e0be7ac0":"markdown","0df135e5":"markdown","69b139cb":"markdown","4ae429d7":"markdown","189a94c7":"markdown","d41a8195":"markdown","00386e55":"markdown","f5a15b59":"markdown","cc72c5bd":"markdown","daf6e1f2":"markdown","84f6855c":"markdown","7ae58108":"markdown","72c77727":"markdown","53134393":"markdown","a7eea79d":"markdown","41fd2c53":"markdown","e8740ee0":"markdown","1d399c40":"markdown","e6b310cb":"markdown","9f8deba3":"markdown","b41696d0":"markdown","b607e4be":"markdown","2c7ae431":"markdown","2e2990fc":"markdown","1e7420c7":"markdown","39e9b0b2":"markdown","0681aa86":"markdown","d93a0c48":"markdown","c9f9e913":"markdown","7e6070fc":"markdown","7dc673a9":"markdown","bd8614e7":"markdown","d67ceeb7":"markdown","b345e977":"markdown","77472d36":"markdown","71251ecc":"markdown","5bf57213":"markdown","f7755fae":"markdown","e74b55a2":"markdown","6271c7f8":"markdown","c5679448":"markdown","125273c5":"markdown","922084a2":"markdown","f5d7c217":"markdown","59c811a7":"markdown","09a2a5be":"markdown","bd844114":"markdown","2414459d":"markdown","d197eac2":"markdown","5f7101ac":"markdown"},"source":{"d31e45ac":"import numpy as np \nimport pandas as pd \nimport seaborn as sns","d8071865":"dataset = pd.read_csv(\"..\/input\/heart-failure-clinical-data\/heart_failure_clinical_records_dataset.csv\") \ndf = dataset.copy()","99109e77":"df.head()","89c36f5d":"df.shape","ef1e383b":"df.isna().sum()","a47b16ac":"df.info()","3c4c090f":"sns.kdeplot(df[\"time\"],color=\"blue\");","14dd39bb":"df[\"time\"].describe()","5d33e86f":"sns.countplot(x = df[\"DEATH_EVENT\"], palette=\"Set1\")","0be83988":"print(df[\"DEATH_EVENT\"].value_counts())","23929b43":"sns.countplot(x = df[\"sex\"], palette = \"Oranges\");","1a94614e":"sns.countplot(x=\"sex\", hue=\"DEATH_EVENT\", data=df, palette=\"Oranges\")","ec7d9df7":"sns.countplot(x = df[\"smoking\"], palette=\"PRGn\");","22b314ee":"sns.countplot(x=\"smoking\", hue=\"DEATH_EVENT\", data=df, palette=\"PRGn\")","fec87f17":"sns.countplot(x = df[\"diabetes\"], palette=\"Set2\")","fa9f92d0":"sns.countplot(x=\"diabetes\", hue=\"DEATH_EVENT\", data=df, palette=\"Set2\")","2a1f7b92":"sns.countplot(x = df[\"anaemia\"], palette=\"Set3\")","231c2412":"sns.countplot(x=\"anaemia\", hue=\"DEATH_EVENT\", data=df, palette=\"Set3\")","acfe2249":"sns.countplot(x = df[\"high_blood_pressure\"], palette=\"coolwarm\")","710b5c95":"sns.countplot(x=\"high_blood_pressure\", hue=\"DEATH_EVENT\", data=df, palette=\"coolwarm\")","0695a956":"sns.kdeplot(df[\"age\"],color=\"purple\");","fcfc7ef5":"sns.violinplot(x = \"DEATH_EVENT\", y = \"age\", data = df, palette = \"PuRd\");","7575199b":"sns.violinplot(x = \"DEATH_EVENT\", y = \"age\", hue=\"smoking\", data = df, palette = \"Reds\");","e1047a9b":"df[\"high_blood_pressure\"].unique()","66edcd1a":"df[\"anaemia\"].unique()","30778508":"df[\"sex\"].unique()","0499018f":"df[\"smoking\"].unique()","2daa904a":"df[\"diabetes\"].unique()","813f7ef8":"df[\"DEATH_EVENT\"].unique()","f2c8ad17":"sns.boxplot(x = df[\"age\"])","c573c3c5":"sns.boxplot(x = df[\"creatinine_phosphokinase\"])","a9a1e3c7":"Q1 = df[\"creatinine_phosphokinase\"].quantile(0.25) # ilk \u00e7eyrek\nQ3 = df[\"creatinine_phosphokinase\"].quantile(0.75) # son \u00e7eyrek\nIQR = Q3 - Q1 \nupperlimit = Q3 + 1.5*IQR #\u00fcst s\u0131n\u0131r\nvaluesabovethelimit = (df[\"creatinine_phosphokinase\"] > (upperlimit)) # \u00fcst s\u0131n\u0131r\u0131n \u00fcst\u00fcndekindaki u\u00e7 de\u011ferler","493f3c96":"df[\"creatinine_phosphokinase\"][valuesabovethelimit] = upperlimit\nsns.boxplot(x = df[\"creatinine_phosphokinase\"])","8f3cc45d":"sns.boxplot(x = df[\"ejection_fraction\"])","4511f025":"Q1 = df[\"ejection_fraction\"].quantile(0.25) \nQ3 = df[\"ejection_fraction\"].quantile(0.75) \nIQR = Q3 - Q1 \nupperlimit = Q3 + 1.5*IQR\nvaluesabovethelimit = (df[\"ejection_fraction\"] > (upperlimit))","21f37196":"df[\"ejection_fraction\"][valuesabovethelimit] = upperlimit\nsns.boxplot(x = df[\"ejection_fraction\"])","c73dc248":"sns.boxplot(x = df[\"platelets\"])","0fef5334":"Q1 = df[\"platelets\"].quantile(0.25) # ilk \u00e7eyrek\nQ3 = df[\"platelets\"].quantile(0.75) # son \u00e7eyrek\nIQR = Q3 - Q1 \nlowerlimit = Q1 - 1.5*IQR # alt s\u0131n\u0131r\nupperlimit = Q3 + 1.5*IQR \nvaluesbelowthelimit = (df[\"platelets\"] < (lowerlimit)) # alt s\u0131n\u0131r\u0131n alt\u0131ndaki u\u00e7 de\u011ferler\nvaluesabovethelimit = (df[\"platelets\"] > (upperlimit)) ","c22cf918":"df[\"platelets\"][valuesabovethelimit] = upperlimit\ndf[\"platelets\"][valuesbelowthelimit] = lowerlimit # alt s\u0131n\u0131r\u0131n alt\u0131nda kalan u\u00e7 de\u011ferleri de de\u011fi\u015ftiriyoruz.\nsns.boxplot(x = df[\"platelets\"])","669c10b6":"sns.boxplot(x = df[\"serum_creatinine\"])","c66950df":"Q1 = df[\"serum_creatinine\"].quantile(0.25) \nQ3 = df[\"serum_creatinine\"].quantile(0.75) \nIQR = Q3 - Q1 \nupperlimit = Q3 + 1.5*IQR\nvaluesabovethelimit = (df[\"serum_creatinine\"] > (upperlimit))","3871aadc":"df[\"serum_creatinine\"][valuesabovethelimit] = upperlimit\nsns.boxplot(x = df[\"serum_creatinine\"])","30f222e9":"sns.boxplot(x = df[\"serum_sodium\"])","d2601f64":"Q1 = df[\"serum_sodium\"].quantile(0.25) # ilk \u00e7eyrek\nQ3 = df[\"serum_sodium\"].quantile(0.75) # son \u00e7eyrek\nIQR = Q3 - Q1 \nlowerlimit = Q1 - 1.5*IQR \nvaluesbelowthelimit = (df[\"serum_sodium\"] < (lowerlimit))","6fd97a60":"df[\"serum_sodium\"][valuesbelowthelimit] = lowerlimit\nsns.boxplot(x = df[\"serum_sodium\"])","0ba51ad2":"sns.boxplot(x = df[\"time\"])","bb2b77a8":"corr = df.corr()\ncorr","b11751af":"corr=df.corr()\nsns.heatmap(corr, \n            xticklabels=corr.columns.values,\n            yticklabels=corr.columns.values);","0897e664":"import matplotlib.pyplot as plt #sonu\u00e7lar\u0131 yorumlamak i\u00e7in grafik olu\u015fturaca\u011f\u0131z\nfrom sklearn.model_selection import train_test_split #verileri e\u011fitim ve test olarak ay\u0131rmak i\u00e7in kullan\u0131lacak\nimport seaborn as sns #karma\u015f\u0131kl\u0131k matrisini g\u00f6r\u00fcnt\u00fclemek i\u00e7in kullan\u0131lacak\nfrom sklearn.preprocessing import MinMaxScaler #verilerimizi \u00f6l\u00e7eklendirmek i\u00e7in min maks \u00f6l\u00e7eklendiriciyi kullanaca\u011f\u0131z\nfrom tensorflow.keras.layers import Dense, BatchNormalization, Dropout, LSTM #yapay sinir a\u011flar\u0131nda katmanlar\u0131 olu\u015ftmak i\u00e7in kullanaca\u011f\u0131z.\nfrom tensorflow.keras.models import Sequential #\u00f6\u011frenme modeli olu\u015fturmak i\u00e7in \nfrom tensorflow.keras import callbacks #early stopping fonksiyonunu kullanmak i\u00e7in y\u00fckledim.\nfrom sklearn.metrics import precision_score, recall_score, confusion_matrix, classification_report, accuracy_score, f1_score # s\u0131n\u0131fland\u0131rma raporu i\u00e7in kullanaca\u011f\u0131z","9ce15924":"X = df.drop(df[['DEATH_EVENT']], axis=1)# Verisetimizi  X ve y olarak b\u00f6l\u00fcyoruz \ny = df[['DEATH_EVENT']] # X giri\u015f verilerimiz y ise \u00e7\u0131k\u0131\u015f verilerimiz yani hedef de\u011fi\u015fkenimiz.\n\nscaler = MinMaxScaler() #\u00d6l\u00e7eklendirme metodu olarak min maks metodunu kullanaca\u011f\u0131z, scaled_data=X-X[min]\/(X[max]-X[min])\nX = scaler.fit_transform(X) # verilerimizi \u00f6l\u00e7eklendirelim.\n\nX_train, X_test, y_train, y_test = train_test_split(X, y, test_size=0.2, random_state=42)# E\u011fitim ve test verisi olarak verileri b\u00f6l\u00fcyoruz\n# Verilerin %80'ini e\u011fitim %20'sini test olarak b\u00f6l\u00fcyoruz.\n#random_state'in de\u011ferinin 42 olmas\u0131 verilerimizi hep 42'den b\u00f6ld\u00fc\u011f\u00fcm\u00fcz anlam\u0131na geliyor. ","86145c91":"early_stopping = callbacks.EarlyStopping( #early stoppin callback fonksiyonudur optimum epoch say\u0131s\u0131n\u0131 bulmak yerine b\u00fcy\u00fck bir epoch say\u0131s\u0131 verilir ve model yeterince \u00f6\u011frendi\u011finde e\u011fitimi durdurur.  \n    min_delta=0.001, #iyile\u015ftirme olarak say\u0131lacak minimum de\u011fi\u015fiklik miktar\u0131\n    patience=20, # bitirmeden \u00f6nce ka\u00e7 epoch daha bekleyece\u011fi\n    restore_best_weights=True # Daha iyi olan a\u011f\u0131r\u015f\u0131\u011f\u0131 \u00f6nceki epochtan geri y\u00fckleyip y\u00fcklemeyece\u011fi.\n)\n#Early_stopping a\u015f\u0131r\u0131 \u00f6\u011frenmenin \u00f6n\u00fcne ge\u00e7er\n\n# S\u0131ral\u0131 modelimizi olu\u015fturmaya ba\u015flat\u0131yoruz. \nmodel = Sequential() # sequential() model olu\u015fturmada yayg\u0131n kullan\u0131lan fonksiyonlardand\u0131r.  \n\n# katmanlar\nmodel.add(Dense(units = 12, activation = 'relu' ))#dense katman \u00f6nceki katmanlardaki b\u00fct\u00fcn n\u00f6ronlar\u0131n bu katmanlardaki b\u00fct\u00fcn n\u00f6ronlara ba\u011fl\u0131 olmas\u0131 demektir.  \nmodel.add(Dense(units = 7, activation = 'relu'))#n\u00f6ron say\u0131s\u0131n\u0131 belirlerken baz\u0131 yakla\u015f\u0131mlar varm\u0131\u015f benim burada kulland\u0131\u011f\u0131m yakla\u015f\u0131m: \n                                                #giri\u015f 12 kolon \u00e7\u0131k\u0131\u015f 1 kolon aritmetik ortalamas\u0131 6,5 buy\u00fczden bir katman 7 di\u011fer katman 6 n\u00f6rondan olu\u015fuyor.\nmodel.add(Dense(units = 6, activation = 'relu'))#Veri setimizde s\u0131f\u0131rdan d\u00fc\u015f\u00fck hi\u00e7 de\u011fer bulunmad\u0131\u011f\u0131ndan relu aktivasyon fonksiyonu bizim i\u00e7in bi\u00e7ilmi\u015f kaftan.\nmodel.add(Dropout(0.5))#dropout fonksiyonu rastgele baz\u0131 n\u00f6ronlar\u0131 kapat\u0131r b\u00f6ylece \u00f6\u011frenme performans\u0131n\u0131 olumlu y\u00f6nde etkiler ve ezberlemeyi \u00f6nemli \u00f6l\u00e7\u00fcde azalt\u0131r.\nmodel.add(Dense(units = 3, activation = 'relu'))\nmodel.add(Dense(units = 1, activation = 'sigmoid')) #sigmoid aktivasyon fonksiyonu tekli s\u0131n\u0131fland\u0131rmalarda kullan\u0131l\u0131r. Girdileri (0,1) ars\u0131na s\u0131k\u0131\u015ft\u0131r\u0131r\n#\u00f6\u011frenmesi gereken 160 parametre var. 17 bias de\u011feri, 143 a\u011f\u0131rl\u0131k. \n\n#Modeli derliyoruz.\nmodel.compile(optimizer = 'adam', loss = 'binary_crossentropy', metrics = ['accuracy'])\n#Adam optimizer en h\u0131zl\u0131 ve en iyi \u015fekilde \u00f6\u011frenen optimizerdir.\n#\u0130kili s\u0131n\u0131fland\u0131rma kullanaca\u011f\u0131m\u0131z i\u00e7in kay\u0131p\/yitim fonksiyonumuz binary_crossentropy'dir.\n#Her bir epoch sonunda validation seti ile elde edilen do\u011fruluk ve loss miktar\u0131n\u0131 g\u00f6rmek i\u00e7in \u201caccuracy\u201d metri\u011fini kullanaca\u011f\u0131z.\n\n# Ysa' e\u011fitiyoruz\nhistory = model.fit(X_train, y_train, batch_size = 32, epochs = 500,callbacks=[early_stopping], validation_split=0.2) #fit fonksiyonuyla e\u011fitiyoruz.\n#E\u011fitime ayn\u0131 anda ka\u00e7 veri girece\u011fini batch_size ile belirliyoruz.\n#Validation_split her epochtan sonra do\u011frulama i\u00e7in verileri b\u00f6ler. ","61cb9062":"val_accuracy = np.mean(history.history['val_accuracy'])\nprint(\"\\n%s: %.2f%%\" % ('val_accuracy', val_accuracy*100))","8f1c0028":"accuracy = np.mean(history.history['accuracy'])\nprint(\"\\n%s: %.2f%%\" % ('accuracy', accuracy*100))","27b61285":"history_df = pd.DataFrame(history.history)\n\nplt.plot(history_df.loc[:, ['loss']], \"#6daa9f\", label='Training loss')\nplt.plot(history_df.loc[:, ['val_loss']],\"#774571\", label='Validation loss')\nplt.title('Training and Validation loss')\nplt.xlabel('Epochs')\nplt.ylabel('Loss')\nplt.legend(loc=\"best\")\n\nplt.show()","ba4e22d2":"history_df = pd.DataFrame(history.history)\n\nplt.plot(history_df.loc[:, ['accuracy']], \"#6daa9f\", label='Training accuracy')\nplt.plot(history_df.loc[:, ['val_accuracy']], \"#774571\", label='Validation accuracy')\n\nplt.title('Training and Validation accuracy')\nplt.xlabel('Epochs')\nplt.ylabel('Accuracy')\nplt.legend()\nplt.show()","1ce2003c":"y_pred = model.predict(X_test)\ny_pred = (y_pred > 0.5)\nnp.set_printoptions()","baf91510":"from sklearn.metrics import confusion_matrix, accuracy_score\nprint(confusion_matrix(y_test, y_pred))\nprint(accuracy_score(y_test, y_pred))","df63ed72":"cmap1 = sns.diverging_palette(275,150,  s=40, l=65, n=6)\nplt.subplots(figsize=(12,8))\ncf_matrix = confusion_matrix(y_test, y_pred)\nsns.heatmap(cf_matrix\/np.sum(cf_matrix), cmap = cmap1, annot = True, annot_kws = {'size':15})","e7c2dbc1":"print(classification_report(y_test, y_pred))","dbe31de4":"Ya\u015f de\u011fi\u015fkeninde ayk\u0131r\u0131 de\u011fer yok.","725d34b5":"Sonu\u00e7 olarak yeterince DEATH_EVENT de\u011feri 1 olan veri yoktur bu y\u00fczden model 1 i\u00e7in do\u011fru tahmin yapam\u0131yor.","c7885bda":"Verisetinde \u00f6l\u00fcm ile sonu\u00e7lanan g\u00f6zlemler daha az. Say\u0131lara bakal\u0131m. ","ecd8f5e8":"Modelimizi haz\u0131rlayal\u0131m ve e\u011fitelim.","074520e7":"Bu de\u011ferler aras\u0131nda; e\u011fer do\u011frulama kay\u0131p\/yitim de\u011ferleri e\u011fitim kay\u0131p\/yitim de\u011ferlerinden b\u00fcy\u00fckse o b\u00f6lgelerde modelimiz -ne kadar b\u00fcy\u00fck oldu\u011funa g\u00f6re farkl\u0131 oranda- ezberliyor demektir.","1175c183":"Hastalar\u0131n diyabet durumunu inceleyelim.","a0fd1493":"\n**Bu projede Derin \u00d6\u011frenme ile bir tahmin sistemi yap\u0131lacakt\u0131r. Kalp yetmezli\u011fi hastalar\u0131ndan toplanm\u0131\u015f verilerle olu\u015fturulmu\u015f bir veriseti kullan\u0131larak gelecek hastalar\u0131n durumunu tahmin edebilecek bir derin \u00f6\u011frenme modeli geli\u015ftirilecektir.**","0033eb9d":"Bu de\u011fi\u015fkenin sadece alt s\u0131n\u0131r\u0131n\u0131n alt\u0131nda u\u00e7 de\u011ferler oldu\u011fu i\u00e7in sadece alt s\u0131n\u0131r\u0131 hesaplayal\u0131m.","a19dbac1":"Bakt\u0131\u011f\u0131m\u0131z \u00f6nceki de\u011ferlere g\u00f6re anemi hastas\u0131 olanlar\u0131n ve olmayanlar\u0131n di\u011fer de\u011ferlere g\u00f6re daha e\u015fit da\u011f\u0131lm\u0131\u015f oldu\u011funu s\u00f6yleyebiliriz. Peki \u00f6l\u00fcme g\u00f6re durumuna bakal\u0131m.","9bc63a69":"De\u011fil. Fakat \u00f6l\u00fcm ile sonu\u00e7lanan g\u00f6zlemlerin nerdeyse yar\u0131 yar\u0131ya daha az oldu\u011funu d\u00fc\u015f\u00fcn\u00fcrsek bu durum daha a\u00e7\u0131klanabilir olur.","fafefd57":"Bu de\u011fi\u015fkenin u\u00e7 de\u011ferleri yok. B\u00f6ylelikle t\u00fcm u\u00e7 de\u011ferleri d\u00fczeltmi\u015f olduk","2ee085a8":"Veri setinde 13 s\u00fctun ve 299 g\u00f6zlem var. Eksik veri var m\u0131 ?","76f2bac4":"Hastalarda keratin y\u00fcksekli\u011fi ve d\u00fc\u015f\u00fckl\u00fc\u011f\u00fc g\u00f6r\u00fclebildi\u011fi i\u00e7in bu de\u011ferler asl\u0131nda yanl\u0131\u015f de\u011fildir. Fakat ileride modelin e\u011fitilmesini etkileyece\u011fi i\u00e7in bu de\u011ferleri de\u011fi\u015ftirmeliyiz. \u00c7\u00fcnk\u00fc 299 g\u00f6zlem zaten modelin e\u011fitilmesi i\u00e7in az bir say\u0131 iken, u\u00e7 de\u011ferlerin olmas\u0131 modeli iyice kar\u0131\u015ft\u0131r\u0131p modelin do\u011frulu\u011funu d\u00fc\u015f\u00fcrebilir. U\u00e7 de\u011ferleri silmek b\u00fcy\u00fck verisetleri i\u00e7in uygun olsa da bizim durumumuzda \u00e7ok fazla g\u00f6zlem kayb\u0131na neden olacakt\u0131r. Bu durumda bask\u0131lama y\u00f6netimini kullanaca\u011f\u0131z.","29a14a99":"Hastalar ne kadar s\u00fcre takip edilmi\u015f?","dd7f8105":"Veri k\u00fcmemizi \u00f6l\u00e7eklendirelim. E\u011fitim ve tes olarak b\u00f6lelim.","e0be7ac0":"Keratin kinaz enzimi i\u00e7in sadece \u00fcst s\u0131n\u0131rdan sonra u\u00e7 de\u011ferler var. Bu u\u00e7 de\u011ferleri \u00fcst s\u0131n\u0131r de\u011feri ile de\u011fi\u015ftirece\u011fiz.","0df135e5":"\u00d6l\u00fcm ile sonu\u00e7lanan kay\u0131tlar ne kadar?","69b139cb":"Anemi hastal\u0131\u011f\u0131na bakal\u0131m.","4ae429d7":"Hastalar\u0131n ne kadar\u0131 sigara i\u00e7iyor?","189a94c7":"De\u011fi\u015fkenlerin tiplerine bakal\u0131m.","d41a8195":"\u0130htiyac\u0131m\u0131z olan k\u00fct\u00fcphaneleri ekleyelim.","00386e55":"Modelimizin e\u011fitim ve do\u011frulama veri k\u00fcmelerindeki ba\u015far\u0131 skorlar\u0131n\u0131 g\u00f6rselle\u015ftirelim ve aralar\u0131ndaki ili\u015fkiyi yorumlayal\u0131m.","f5a15b59":"Karma\u015f\u0131kl\u0131k matrisini y\u00fczdeler cinsinden g\u00f6rselle\u015ftirelim ve yorumlayal\u0131m.","cc72c5bd":"G\u00f6zlemler i\u00e7erisinde en az 4 g\u00fcn, en fazla 285 g\u00fcn takip edilmi\u015f hastalar var. Ortalama takip s\u00fcresi ise 130 g\u00fcn.","daf6e1f2":"S\u00fctunlar s\u0131ras\u0131yla hastalar\u0131n ya\u015f\u0131, anemi durumunu, kandaki keratin kinaz enzimi seviyesi, diyabet durumunu, kalbin her kas\u0131lmada pompalad\u0131\u011f\u0131 kan y\u00fczdesi, hipertansiyon durumu, kandaki trombositler, kandaki serum kreatinin d\u00fczeyi, kandaki serum sodyumun d\u00fczeyi, cinsiyeti, sigara i\u00e7ip i\u00e7memesi, hastan\u0131n takip s\u00fcresi ve \u00f6l\u00fcm durumunu i\u00e7eriyor.","84f6855c":"# Model Olu\u015fturma","7ae58108":"Binary de\u011ferler alan de\u011fi\u015fkenleri bu \u015fekilde kontrol ettik. Ya\u015f gibi de\u011fi\u015fkenleri bu \u015fekilde kontrol etmek ise anla\u015f\u0131lmaz olacakt\u0131r. Bunun i\u00e7in Boxplot kullanaca\u011f\u0131z.","72c77727":"\u00dcst s\u0131n\u0131rda ve alt s\u0131n\u0131rda u\u00e7 de\u011fi\u015fkenler var. Bu nedenle alt s\u0131n\u0131r\u0131 da hesaplayaca\u011f\u0131z.","53134393":"Daha kolay okuyabilmek i\u00e7in \u0131s\u0131 haritas\u0131 olu\u015ftural\u0131m.","a7eea79d":"\u015eimdi verisetindeki eksik ve u\u00e7 veriler ile ilgilenelim. Eksik veri olmad\u0131\u011f\u0131n\u0131 g\u00f6rm\u00fc\u015ft\u00fck fakat eksik veri 0'dan da farkl\u0131 olabilece\u011fi i\u00e7in de\u011fi\u015fenlerin benzersiz de\u011ferlerini kontrol edelim. ","41fd2c53":"Hipertansiyon hastalar\u0131na bakal\u0131m.","e8740ee0":"Modelimiz i\u00e7in ay\u0131rd\u0131\u011f\u0131m\u0131z test verileri i\u00e7in tahmin ettirelim. ","1d399c40":"Accuracy de\u011feri %85'ye kadar \u00e7\u0131kmaktad\u0131r. Validation accuracy de\u011feri y\u00fckselmi\u015ftir. ","e6b310cb":"Veriler karars\u0131zd\u0131r, bu y\u00fczden \u00f6l\u00e7eklendirmemiz gerekir. Yoksa farkl\u0131 birimdeki veriler i\u00e7in olu\u015fan de\u011fi\u015fim de\u011ferleri ayn\u0131 \u015fekilde yorumlan\u0131r bunun i\u00e7in \u00f6l\u00e7eklendirme gerekir. \u00d6rne\u011fin serum kreatin verilerindeki +1, -1 de\u011fi\u015fim \u00e7ok \u00f6nemlidir ama ya\u015f de\u011feri i\u00e7in +1 -1 de\u011fi\u015fim \u00f6nemli de\u011fildir bu y\u00fczden verilerimizi \u00f6l\u00e7eklendirmeliyiz","9f8deba3":"Veri setinin kopyas\u0131 \u00fczerinde \u00e7al\u0131\u015faca\u011f\u0131z.","b41696d0":"Peki bu durumu sigara da etkiliyor mu?","b607e4be":"Veri seti birka\u00e7 g\u00fcn takip edilen hastalardan, 200 g\u00fcnden fazla takip edilen hastalara kadar geni\u015f bir aral\u0131kta. Bunu daha net g\u00f6rebilmek i\u00e7in tam de\u011ferleri de kontrol edelim.","2c7ae431":"\u00c7o\u011fu de\u011fi\u015fkenin birbirleri ile aralar\u0131ndaki korelasyon ili\u015fkisinin zay\u0131f oldu\u011funu s\u00f6yleyebiliriz. Aralar\u0131nda en g\u00fc\u00e7l\u00fc ve pozitif korelasyon ili\u015fkisi sex ve smoking de\u011ferleri aras\u0131nda. En negatif ili\u015fki ise time ve DEATH_EVENT de\u011fi\u015fkenleri aras\u0131ndaki negatif ve zay\u0131f ili\u015fki.","2e2990fc":"Hastalar\u0131n ya\u015f da\u011f\u0131l\u0131m\u0131 nas\u0131l?","1e7420c7":"De\u011ferler aras\u0131ndaki korelasyonu inceleyelim.","39e9b0b2":"G\u00f6zlemlerin cinsiyet da\u011f\u0131l\u0131m\u0131 nas\u0131l?","0681aa86":"Bask\u0131lama i\u015fleminden sonra keratin kinaz de\u011fi\u015fkeninde u\u00e7 de\u011fer kalmad\u0131. Bu i\u015flemi di\u011fer de\u011fi\u015fkenler i\u00e7in de yapaca\u011f\u0131z.","d93a0c48":"E\u011fitim ve do\u011frulama kay\u0131p\/yitim de\u011ferleri ayn\u0131 de\u011ferde ba\u015fl\u0131yorlar. Modelimiz ezberlemeye ba\u015fl\u0131yor. Daha sonra art\u0131k min_delta 0.001'in alt\u0131na inince early_stopping fonksiyonumuz 20 epoch daha bekledikten sonra E\u011fitimi durduyor.","c9f9e913":"Erkeklerde kad\u0131nlardan daha fazla \u00f6l\u00fcm vard\u0131r diyebilir miyiz ? Elimizde 299 veri oldu\u011fu i\u00e7in bu kadar genel bir \u00e7\u0131kar\u0131m yapmak tutarl\u0131 olmaz.","7e6070fc":"Grafi\u011fe bakarsak veri setinde 40 ya\u015f\u0131ndan daha gen\u00e7 hasta olmad\u0131\u011f\u0131n\u0131 ve tahminen 95 ya\u015f\u0131ndan daha ya\u015fl\u0131 hasta olmad\u0131\u011f\u0131n\u0131 s\u00f6yleyebiliriz. Hastalar 60 ya\u015flar\u0131nda yo\u011funla\u015f\u0131yor. \u00d6l\u00fcmler hangi ya\u015f aral\u0131klar\u0131nda daha fazla?","7dc673a9":"Do\u011frulama ve e\u011fitim verisetindeki ba\u015far\u0131 skorlar\u0131n\u0131n aritmetik ortalamar\u0131n\u0131 g\u00f6relim.","bd8614e7":"# Kesif\u00e7i Veri Analizi","d67ceeb7":"Validation accuray'nin ortalamas\u0131 yeni gelecek veriler i\u00e7in do\u011fru tahmin olas\u0131l\u0131\u011f\u0131n\u0131 g\u00f6sterir.","b345e977":"Grafi\u011fe bakarsak bu verisetine g\u00f6re fazla etkilemiyor.","77472d36":"Veristeinde \u00f6l\u00fcm ile sonu\u00e7lanmayan vakalar yakla\u015f\u0131k 2 kat daha fazla. \u0130lerideki yorumlarda bunu g\u00f6z \u00f6n\u00fcnde bulundural\u0131m.","71251ecc":"\u0130ki tane u\u00e7 de\u011fer var ve \u00fcst s\u0131n\u0131r\u0131n \u00fcst\u00fcndeler.","5bf57213":"Karma\u015f\u0131kl\u0131k matrisini ve do\u011fruluk skorunu yazd\u0131ral\u0131m.","f7755fae":"0 kad\u0131n, 1 erkek cinsiyeti i\u00e7in kullan\u0131l\u0131yor. G\u00f6zlemlerin i\u00e7inde erkek hastalar daha fazla. Peki \u00f6l\u00fcm oranlar\u0131 nas\u0131l ?","e74b55a2":"# Veri \u00d6n \u0130\u015fleme","6271c7f8":"Eksik veri yok.","c5679448":"E\u011fitim veri setindeki ortalama ba\u015far\u0131s\u0131.","125273c5":"Verinin ilk 5 g\u00f6zlemine g\u00f6z gezdirelim ve veride toplamda ka\u00e7 g\u00f6zlem oldu\u011funa bakal\u0131m.","922084a2":"E\u011fitim ve Do\u011frulama veri k\u00fcmelerinde kay\u0131p\/yitim de\u011ferlerini g\u00f6rselle\u015ftirelim ve aralar\u0131ndaki ili\u015fkiyi yorumlayal\u0131m","f5d7c217":"# **KALP YETMEZL\u0130\u011e\u0130 TAHM\u0130N\u0130**","59c811a7":"**Vakit Ay\u0131rd\u0131\u011f\u0131n\u0131z \u0130\u00e7in Te\u015fekk\u00fcrler**","09a2a5be":"Diyabetli hastalarda \u00f6l\u00fcm daha fazla m\u0131?","bd844114":"T\u00fcm test verisinin %70'i do\u011fru tahmin edilmi\u015ftir. As\u0131l de\u011feri 0 olan de\u011ferlerin (ya\u015fayanlar\u0131n) neredeyse hepsini do\u011fru tahmin etmi\u015ftir ancak as\u0131l de\u011feri 1 olanlar\u0131n (vefat edenlerin) yar\u0131s\u0131ndan fazlas\u0131n\u0131 yanl\u0131\u015f tahmin etmi\u015ftir.","2414459d":"\u015eimdi verisetini grafikler ile inceleyelim.","d197eac2":"E\u011fitim ba\u015far\u0131s\u0131 artarak ilerlerken do\u011frulama ba\u015far\u0131s\u0131 zaman zaman azalm\u0131\u015ft\u0131r.","5f7101ac":"Peki sigara \u00f6l\u00fcmleri etkiliyor mu ?"}}